Article: Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline.

Byline: Trista Morrison, Staff Writer

Anacor Pharmaceuticals Inc. capped off a busy month for IPO filings Friday, becoming the 10th biotech to file for an initial public offering in August.

Anacor's proposal to raise up to $57.5 million followed bids from ARYx Therapeutics Inc., Adnexus Therapeutics Inc., Insys Therapeutics Inc., Precision Therapeutics Inc., Biolex Inc., Nanosphere Inc., Peplin Inc., Reliant Pharmaceuticals Inc. and Genoptix Inc.

Proceeds from Anacor's offering will support the Palo Alto, Calif.-based company's development of topically-administered small molecules derived from its boron chemistry platform. A naturally occurring ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!